335 related articles for article (PubMed ID: 28347184)
21. Effects of continuous long-term testosterone therapy (TTh) on anthropometric, endocrine and metabolic parameters for up to 10 years in 115 hypogonadal elderly men: real-life experience from an observational registry study.
Yassin AA; Nettleship J; Almehmadi Y; Salman M; Saad F
Andrologia; 2016 Sep; 48(7):793-9. PubMed ID: 26762680
[TBL] [Abstract][Full Text] [Related]
22. Long-term effect of testosterone therapy on bone mineral density in hypogonadal men.
Behre HM; Kliesch S; Leifke E; Link TM; Nieschlag E
J Clin Endocrinol Metab; 1997 Aug; 82(8):2386-90. PubMed ID: 9253305
[TBL] [Abstract][Full Text] [Related]
23. Effects of long-term testosterone replacement therapy, with a temporary intermission, on glycemic control of nine hypogonadal men with type 1 diabetes mellitus - a series of case reports.
Saad F; Yassin A; Almehmadi Y; Doros G; Gooren L
Aging Male; 2015; 18(3):164-8. PubMed ID: 26075537
[TBL] [Abstract][Full Text] [Related]
24. The contribution of hypogonadism to the development of osteoporosis in thalassaemia major: new therapeutic approaches.
Anapliotou ML; Kastanias IT; Psara P; Evangelou EA; Liparaki M; Dimitriou P
Clin Endocrinol (Oxf); 1995 Mar; 42(3):279-87. PubMed ID: 7758233
[TBL] [Abstract][Full Text] [Related]
25. Long-term treatment patterns of testosterone replacement medications.
Donatucci C; Cui Z; Fang Y; Muram D
J Sex Med; 2014 Aug; 11(8):2092-9. PubMed ID: 24909541
[TBL] [Abstract][Full Text] [Related]
26. Bone mineral density outcomes following long-term treatment with subcutaneous testosterone pellet implants in male hypogonadism.
Zacharin MR; Pua J; Kanumakala S
Clin Endocrinol (Oxf); 2003 Jun; 58(6):691-5. PubMed ID: 12780744
[TBL] [Abstract][Full Text] [Related]
27. Testosterone Therapy Effects on Bone Mass and Turnover in Hypogonadal Men with Type 2 Diabetes.
Colleluori G; Aguirre L; Napoli N; Qualls C; Villareal DT; Armamento-Villareal R
J Clin Endocrinol Metab; 2021 Jul; 106(8):e3058-e3068. PubMed ID: 33735389
[TBL] [Abstract][Full Text] [Related]
28. Bone benefits of testosterone replacement therapy in male hypogonadism.
Tirabassi G; Biagioli A; Balercia G
Panminerva Med; 2014 Jun; 56(2):151-63. PubMed ID: 24994579
[TBL] [Abstract][Full Text] [Related]
29. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial.
Marks LS; Mazer NA; Mostaghel E; Hess DL; Dorey FJ; Epstein JI; Veltri RW; Makarov DV; Partin AW; Bostwick DG; Macairan ML; Nelson PS
JAMA; 2006 Nov; 296(19):2351-61. PubMed ID: 17105798
[TBL] [Abstract][Full Text] [Related]
30. Testosterone replacement therapy among elderly males: the Testim Registry in the US (TRiUS).
Bhattacharya RK; Khera M; Blick G; Kushner H; Miner MM
Clin Interv Aging; 2012; 7():321-30. PubMed ID: 22956867
[TBL] [Abstract][Full Text] [Related]
31. Effects of testosterone replacement therapy withdrawal and re-treatment in hypogonadal elderly men upon obesity, voiding function and prostate safety parameters.
Yassin A; Nettleship JE; Talib RA; Almehmadi Y; Doros G
Aging Male; 2016; 19(1):64-9. PubMed ID: 26742589
[TBL] [Abstract][Full Text] [Related]
32. Osteoporosis in men with hypogonadism because of ApoA-I Leu75Pro amyloidosis under long-term testosterone therapy.
Facondo P; Delbarba A; Pezzaioli LC; Ferlin A; Cappelli C
Andrology; 2023 Sep; 11(6):1077-1085. PubMed ID: 36624081
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of testosterone replacement therapy on pain in hypogonadal men with chronic pain syndrome: A subanalysis of a prospective randomised controlled study in Japan (EARTH study).
Kato Y; Shigehara K; Kawaguchi S; Izumi K; Kadono Y; Mizokami A
Andrologia; 2020 Oct; 52(9):e13768. PubMed ID: 32706428
[TBL] [Abstract][Full Text] [Related]
34. Serum adiponectin levels in hypogonadal males: influence of testosterone replacement therapy.
Lanfranco F; Zitzmann M; Simoni M; Nieschlag E
Clin Endocrinol (Oxf); 2004 Apr; 60(4):500-7. PubMed ID: 15049966
[TBL] [Abstract][Full Text] [Related]
35. [Effect of immunosuppression-induced hypogonadism on bone metabolism after heart transplantation].
Stief J; Sohn HY; Alt A; Uberfuhr P; Theisen K; Stempfle HU
Dtsch Med Wochenschr; 2004 Jul; 129(31-32):1674-8. PubMed ID: 15273918
[TBL] [Abstract][Full Text] [Related]
36. Re: Effects of Testosterone Replacement Therapy on Hypogonadal Men with Osteopenia or Osteoporosis: A Subanalysis of a Prospective Randomized Controlled Study in Japan (EARTH Study).
Seftel AD
J Urol; 2017 Sep; 198(3):468. PubMed ID: 28817886
[No Abstract] [Full Text] [Related]
37. Efficacy of changing testosterone gel preparations (Androgel or Testim) among suboptimally responsive hypogonadal men.
Grober ED; Khera M; Soni SD; Espinoza MG; Lipshultz LI
Int J Impot Res; 2008; 20(2):213-7. PubMed ID: 17898800
[TBL] [Abstract][Full Text] [Related]
38. MYTHS AND CONTROVERSIES IN HYPOGONADISM TREATMENT OF AGING MALES.
Ungureanu MC; Costache II; Preda C; Mogoş V; Vulpoi C; Leuştean L
Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):325-33. PubMed ID: 26204632
[TBL] [Abstract][Full Text] [Related]
39. Effects of 8-Year Treatment of Long-Acting Testosterone Undecanoate on Metabolic Parameters, Urinary Symptoms, Bone Mineral Density, and Sexual Function in Men With Late-Onset Hypogonadism.
Permpongkosol S; Khupulsup K; Leelaphiwat S; Pavavattananusorn S; Thongpradit S; Petchthong T
J Sex Med; 2016 Aug; 13(8):1199-211. PubMed ID: 27436076
[TBL] [Abstract][Full Text] [Related]
40. Effect of testosterone replacement on trabecular architecture in hypogonadal men.
Benito M; Vasilic B; Wehrli FW; Bunker B; Wald M; Gomberg B; Wright AC; Zemel B; Cucchiara A; Snyder PJ
J Bone Miner Res; 2005 Oct; 20(10):1785-91. PubMed ID: 16160736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]